CEO Bryan Hanson told investors last week that the restructuring plan would save Solventum $120 million annually.

Solventum (NYSE: SOLV), the leader in dental composites and restorative dentistry, today announced a strategic partnership ...

The Journal reported in October that Solventum, the healthcare company spun off from 3M last year, had retained bankers to explore a sale of its purification and filtration unit.

Solventum has a 12-month low of $47.16 and a 12-month high of $85.92. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. Institutional Trading of ...

MAPLEWOOD, Minn. (AP) — MAPLEWOOD, Minn. (AP) — Solventum Corp. (SOLV) on Thursday reported fourth-quarter net income of $30 million. The Maplewood, Minnesota-based company said it had net ...

Solventum (SOLV) announced it has entered into a definitive agreement to sell its Purification & Filtration business to Thermo Fisher Scientific (TMO) for $4.1B. Solventum expects the transaction ...

To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Solventum, the 3M healthcare spinoff, eliminated 800 positions as part of a restructuring strategy to help ...